ASCO GU 2021

Complete Coverage

Palliative Care Use in Advanced Renal Cell Carcinoma Linked to Socioeconomic Groups

Researchers sought to determine accessibility and use of palliative care among patients with advanced renal cell carcinoma.

Bladder Pressure May Influence Intravesical Drug Delivery

Using porcine bladders, researchers investigated whether bladder pressure affects the extent to which gemcitabine penetrates the bladder wall with this treatment modality.

Demographic Factors With Stage at Diagnosis and Use of Treatment in Bladder Cancer

Researchers sought to identify social disparities in diagnosis and treatment among patients with bladder cancer.

Tumor Mutational Burden, Immune-Related Adverse Events in Metastatic Urothelial Cancer

Researchers analyzed data from patients with metastatic urothelial cancer to determine whether tumor mutation burden was associated with immune-related AEs among patients treated with immune checkpoint inhibitors.

Geriatric Assessment Predictive of Outcomes of Radical Cystectomy for Bladder Cancer

Prospective cohort study sought to determine the association between impairments identified through GA and outcomes of radical cystectomy for bladder cancer.

Perceptions of Goals, Challenges Regarding Shared Decision-Making in Bladder Cancer Care

Results of a survey show differences between patients and healthcare providers regarding key aspects of bladder cancer treatment and outcomes.

Discussions on Financial Toxicity, Impact on Work Need Improvement, Report Patients With Prostate Cancer

Study reveals patients’ and survivors’ perception of discussions with their healthcare team regarding options, costs, and impact on work related to prostate cancer treatment.

Some Outcomes for Patients Undergoing Radical Cystectomy Differ Between the Sexes

Researchers present data comparing outcomes of radical cystectomy for female and male patients with bladder cancer.

Early Quality-of-Life Declines Predict Need for Intervention in Patients With Prostate Cancer Receiving Radiotherapy

Using the EPIC-CP tool, researchers sought to determine if early patient reports of quality of life improved over time in patients undergoing radiotherapy for prostate cancer.

Bone-Targeted Therapies and Incidence of Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Carcinoma

A retrospective analysis evaluated the incidence of ONJ in patients who received VEGF-TKIs or immune-oncology therapy for mRCC and bone-targeted therapies for bone metastases.

Noncompletion Rates of SBRT Compared With Conventional Fractionation in Radiotherapy for Localized Prostate Cancer

Data analysis evaluated the associations between rates of treatment noncompletion and radiotherapy fractionation schedules for men with localized prostate cancer.

Comparison of Lenvatinib Starting Dosages Assessed HRQOL, TTD in Previously Treated RCC

Researchers compared health-related quality of life and time to deterioration for patients with RCC treated with 2 starting doses of lenvatinib, combined with everolimus.

Depression Common After Prostate Cancer Diagnosis, Incidence Higher in Black Men

Retrospective study of more than 32,000 veterans sought to determine the incidence, management, and mortality of men with prostate cancer who experience depression.

Effect of Hypertension History on Outcomes in Patients With Metastatic Renal Cell Carcinoma

A retrospective analysis sought to determine the effect of hypertension on overall survival, response, and progression-free survival in patients with mRCC.